Isofol Medical AB (publ)
LEI 549300MCXYAHG7VBHX75 · QID Q115167197
| Fact | Value | Period | Source |
|---|---|---|---|
| cash_and_equivalents | {"amount": 190583000.0, "concept": "ifrs-full:CashAndCashEquivalents"} | 2022-12-31 | esef |
| cash_and_equivalents | {"amount": 379448000.0, "concept": "ifrs-full:CashAndCashEquivalents"} | 2021-12-31 | esef |
| cash_and_equivalents | {"amount": 116393000.0, "concept": "ifrs-full:CashAndCashEquivalents"} | 2020-12-31 | esef |
| cashflow_financing | {"amount": -1681000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"} | 2022-12-31 | esef |
| cashflow_financing | {"amount": 450477000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"} | 2021-12-31 | esef |
| cashflow_investing | {"amount": 0.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} | 2022-12-31 | esef |
| cashflow_investing | {"amount": 0.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} | 2021-12-31 | esef |
| cashflow_operating | {"amount": -190975000.0, "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities"} | 2022-12-31 | esef |
| cashflow_operating | {"amount": -188429000.0, "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities"} | 2021-12-31 | esef |
| current_assets | {"amount": 209451000.0, "concept": "ifrs-full:CurrentAssets"} | 2022-12-31 | esef |
| current_assets | {"amount": 394609000.0, "concept": "ifrs-full:CurrentAssets"} | 2021-12-31 | esef |
| current_liabilities | {"amount": 51735000.0, "concept": "ifrs-full:CurrentLiabilities"} | 2022-12-31 | esef |
| current_liabilities | {"amount": 83020000.0, "concept": "ifrs-full:CurrentLiabilities"} | 2021-12-31 | esef |
| entity_legal_form | {"value": "XJHM", "elf_code": "XJHM"} | gleif | |
| eps_basic | {"amount": -0.99, "concept": "ifrs-full:BasicEarningsLossPerShare"} | 2022-12-31 | esef |
| eps_basic | {"amount": -1.59, "concept": "ifrs-full:BasicEarningsLossPerShare"} | 2021-12-31 | esef |
| eps_diluted | {"amount": -0.99, "concept": "ifrs-full:DilutedEarningsLossPerShare"} | 2022-12-31 | esef |
| eps_diluted | {"amount": -1.59, "concept": "ifrs-full:DilutedEarningsLossPerShare"} | 2021-12-31 | esef |
| headquarters_address | {"city": "Göteborg", "region": "SE-O", "street": "C/O Biotech Center, Arvid Wallgrens, Bac | gleif | |
| ifrs:AccrualsAndDeferredIncomeIncludingContractLiabilities | {"amount": 40881000.0} | 2022-12-31 | esef |
| ifrs:AccrualsAndDeferredIncomeIncludingContractLiabilities | {"amount": 62110000.0} | 2021-12-31 | esef |
| ifrs:AdditionalPaidinCapital | {"amount": 1217607000.0} | 2022-12-31 | esef |
| ifrs:AdditionalPaidinCapital | {"amount": 1217607000.0} | 2021-12-31 | esef |
| ifrs:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables | {"amount": -504000.0} | 2022-12-31 | esef |
| ifrs:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables | {"amount": 9860000.0} | 2021-12-31 | esef |
| ifrs:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables | {"amount": -31166000.0} | 2022-12-31 | esef |
| ifrs:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables | {"amount": 4907000.0} | 2021-12-31 | esef |
| ifrs:Assets | {"amount": 213464000.0} | 2022-12-31 | esef |
| ifrs:Assets | {"amount": 401363000.0} | 2021-12-31 | esef |
| ifrs:BasicEarningsLossPerShare | {"amount": -0.99} | 2022-12-31 | esef |
| ifrs:BasicEarningsLossPerShare | {"amount": -1.59} | 2021-12-31 | esef |
| ifrs:CashAndCashEquivalents | {"amount": 190583000.0} | 2022-12-31 | esef |
| ifrs:CashAndCashEquivalents | {"amount": 379448000.0} | 2021-12-31 | esef |
| ifrs:CashAndCashEquivalents | {"amount": 116393000.0} | 2020-12-31 | esef |
| ifrs:CashFlowsFromUsedInFinancingActivities | {"amount": -1681000.0} | 2022-12-31 | esef |
| ifrs:CashFlowsFromUsedInFinancingActivities | {"amount": 450477000.0} | 2021-12-31 | esef |
| ifrs:CashFlowsFromUsedInInvestingActivities | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:CashFlowsFromUsedInInvestingActivities | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:CashFlowsFromUsedInOperatingActivities | {"amount": -190975000.0} | 2022-12-31 | esef |
| ifrs:CashFlowsFromUsedInOperatingActivities | {"amount": -188429000.0} | 2021-12-31 | esef |
| ifrs:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital | {"amount": -159305000.0} | 2022-12-31 | esef |
| ifrs:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital | {"amount": -203196000.0} | 2021-12-31 | esef |
| ifrs:ComprehensiveIncome | {"amount": -200251000.0} | 2021-12-31 | esef |
| ifrs:ComprehensiveIncome | {"amount": -159755000.0} | 2022-12-31 | esef |
| ifrs:CurrentAssets | {"amount": 209451000.0} | 2022-12-31 | esef |
| ifrs:CurrentAssets | {"amount": 394609000.0} | 2021-12-31 | esef |
| ifrs:CurrentLiabilities | {"amount": 51735000.0} | 2022-12-31 | esef |
| ifrs:CurrentLiabilities | {"amount": 83020000.0} | 2021-12-31 | esef |
| ifrs:CurrentPrepaidExpenses | {"amount": 1215000.0} | 2022-12-31 | esef |
| ifrs:CurrentPrepaidExpenses | {"amount": 2884000.0} | 2021-12-31 | esef |
| ifrs:DepreciationAndAmortisationExpense | {"amount": 1642000.0} | 2022-12-31 | esef |
| ifrs:DepreciationAndAmortisationExpense | {"amount": 1596000.0} | 2021-12-31 | esef |
| ifrs:DilutedEarningsLossPerShare | {"amount": -0.99} | 2022-12-31 | esef |
| ifrs:DilutedEarningsLossPerShare | {"amount": -1.59} | 2021-12-31 | esef |
| ifrs:EffectOfExchangeRateChangesOnCashAndCashEquivalents | {"amount": 3791000.0} | 2022-12-31 | esef |
| ifrs:EffectOfExchangeRateChangesOnCashAndCashEquivalents | {"amount": 1007000.0} | 2021-12-31 | esef |
| ifrs:EmployeeBenefitsExpense | {"amount": 34748000.0} | 2022-12-31 | esef |
| ifrs:EmployeeBenefitsExpense | {"amount": 27721000.0} | 2021-12-31 | esef |
| ifrs:Equity | {"amount": 158479000.0} | 2022-12-31 | esef |
| ifrs:Equity | {"amount": 318233000.0} | 2021-12-31 | esef |
| ifrs:Equity | {"amount": 66567000.0} | 2020-12-31 | esef |
| ifrs:EquityAndLiabilities | {"amount": 213464000.0} | 2022-12-31 | esef |
| ifrs:EquityAndLiabilities | {"amount": 401363000.0} | 2021-12-31 | esef |
| ifrs:FinanceCosts | {"amount": 44000.0} | 2022-12-31 | esef |
| ifrs:FinanceCosts | {"amount": 168000.0} | 2021-12-31 | esef |
| ifrs:FinanceIncome | {"amount": 7750000.0} | 2022-12-31 | esef |
| ifrs:FinanceIncome | {"amount": 4383000.0} | 2021-12-31 | esef |
| ifrs:FinanceIncomeCost | {"amount": 7706000.0} | 2022-12-31 | esef |
| ifrs:FinanceIncomeCost | {"amount": 4215000.0} | 2021-12-31 | esef |
| ifrs:IncomeTaxesPaidRefundClassifiedAsOperatingActivities | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:IncomeTaxesPaidRefundClassifiedAsOperatingActivities | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:IncomeTaxExpenseContinuingOperations | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:IncomeTaxExpenseContinuingOperations | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | {"amount": -192656000.0} | 2022-12-31 | esef |
| ifrs:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | {"amount": 262048000.0} | 2021-12-31 | esef |
| ifrs:IncreaseDecreaseInWorkingCapital | {"amount": 31670000.0} | 2022-12-31 | esef |
| ifrs:IncreaseDecreaseInWorkingCapital | {"amount": -14767000.0} | 2021-12-31 | esef |
| ifrs:IncreaseDecreaseThroughTransactionsWithOwners | {"amount": 451917000.0} | 2021-12-31 | esef |
| ifrs:IntangibleAssetsAndGoodwill | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:IntangibleAssetsAndGoodwill | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:IntangibleAssetsOtherThanGoodwill | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:IntangibleAssetsOtherThanGoodwill | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:IssuedCapital | {"amount": 4945000.0} | 2022-12-31 | esef |
| ifrs:IssuedCapital | {"amount": 4945000.0} | 2021-12-31 | esef |
| ifrs:Liabilities | {"amount": 54985000.0} | 2022-12-31 | esef |
| ifrs:Liabilities | {"amount": 83130000.0} | 2021-12-31 | esef |
| ifrs:NoncurrentAssets | {"amount": 4013000.0} | 2022-12-31 | esef |
| ifrs:NoncurrentAssets | {"amount": 6755000.0} | 2021-12-31 | esef |
| ifrs:NoncurrentFinancialAssets | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:NoncurrentFinancialAssets | {"amount": 5009000.0} | 2021-12-31 | esef |
| ifrs:NoncurrentLeaseLiabilities | {"amount": 2405000.0} | 2022-12-31 | esef |
| ifrs:NoncurrentLeaseLiabilities | {"amount": 110000.0} | 2021-12-31 | esef |
| ifrs:NoncurrentLiabilities | {"amount": 3250000.0} | 2022-12-31 | esef |
| ifrs:NoncurrentLiabilities | {"amount": 110000.0} | 2021-12-31 | esef |
| ifrs:OperatingExpense | {"amount": 180316000.0} | 2022-12-31 | esef |
| ifrs:OperatingExpense | {"amount": 226872000.0} | 2021-12-31 | esef |
| ifrs:OtherAdjustmentsForNoncashItems | {"amount": 450000.0} | 2022-12-31 | esef |
| ifrs:OtherAdjustmentsForNoncashItems | {"amount": -2946000.0} | 2021-12-31 | esef |
| ifrs:OtherComprehensiveIncome | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:OtherComprehensiveIncome | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:OtherExpenseByNature | {"amount": 142114000.0} | 2022-12-31 | esef |
| ifrs:OtherExpenseByNature | {"amount": 196712000.0} | 2021-12-31 | esef |
| ifrs:OtherGainsLosses | {"amount": -1812000.0} | 2022-12-31 | esef |
| ifrs:OtherGainsLosses | {"amount": -843000.0} | 2021-12-31 | esef |
| ifrs:OtherIncome | {"amount": 59000.0} | 2022-12-31 | esef |
| ifrs:OtherIncome | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:OtherLiabilities | {"amount": 3334000.0} | 2022-12-31 | esef |
| ifrs:OtherLiabilities | {"amount": 3174000.0} | 2021-12-31 | esef |
| ifrs:OtherNoncurrentFinancialAssets | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:OtherNoncurrentFinancialAssets | {"amount": 5009000.0} | 2021-12-31 | esef |
| ifrs:OtherPropertyPlantAndEquipment | {"amount": 4013000.0} | 2022-12-31 | esef |
| ifrs:OtherPropertyPlantAndEquipment | {"amount": 1745000.0} | 2021-12-31 | esef |
| ifrs:OtherProvisions | {"amount": 845000.0} | 2022-12-31 | esef |
| ifrs:OtherProvisions | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:OtherReceivables | {"amount": 17652000.0} | 2022-12-31 | esef |
| ifrs:OtherReceivables | {"amount": 12276000.0} | 2021-12-31 | esef |
| ifrs:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | {"amount": 1704000.0} | 2022-12-31 | esef |
| ifrs:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | {"amount": 1548000.0} | 2021-12-31 | esef |
| ifrs:ProceedsFromIssuingOtherEquityInstruments | {"amount": 23000.0} | 2022-12-31 | esef |
| ifrs:ProceedsFromIssuingOtherEquityInstruments | {"amount": 108000.0} | 2021-12-31 | esef |
| ifrs:ProceedsFromIssuingShares | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:ProceedsFromIssuingShares | {"amount": 451917000.0} | 2021-12-31 | esef |
| ifrs:ProfitLoss | {"amount": -159755000.0} | 2022-12-31 | esef |
| ifrs:ProfitLoss | {"amount": -200251000.0} | 2021-12-31 | esef |
| ifrs:ProfitLossAttributableToOwnersOfParent | {"amount": -159755000.0} | 2022-12-31 | esef |
| ifrs:ProfitLossAttributableToOwnersOfParent | {"amount": -200251000.0} | 2021-12-31 | esef |
| ifrs:ProfitLossBeforeTax | {"amount": -159755000.0} | 2022-12-31 | esef |
| ifrs:ProfitLossBeforeTax | {"amount": -200251000.0} | 2021-12-31 | esef |
| ifrs:ProfitLossFromOperatingActivities | {"amount": -167460000.0} | 2022-12-31 | esef |
| ifrs:ProfitLossFromOperatingActivities | {"amount": -204465000.0} | 2021-12-31 | esef |
| ifrs:PropertyPlantAndEquipment | {"amount": 4013000.0} | 2022-12-31 | esef |
| ifrs:PropertyPlantAndEquipment | {"amount": 1745000.0} | 2021-12-31 | esef |
| ifrs:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | {"amount": 0.0} | 2021-12-31 | esef |
| ifrs:RetainedEarnings | {"amount": -904319000.0} | 2022-12-31 | esef |
| ifrs:RetainedEarnings | {"amount": -704069000.0} | 2021-12-31 | esef |
| ifrs:Revenue | {"amount": 12797000.0} | 2022-12-31 | esef |
| ifrs:Revenue | {"amount": 22407000.0} | 2021-12-31 | esef |
| ifrs:RevenueAndOperatingIncome | {"amount": 12856000.0} | 2022-12-31 | esef |
| ifrs:RevenueAndOperatingIncome | {"amount": 22407000.0} | 2021-12-31 | esef |
| ifrs:ShareIssueRelatedCost | {"amount": 48240000.0} | 2021-12-31 | esef |
| ifrs:TradeAndOtherCurrentPayables | {"amount": 7520000.0} | 2022-12-31 | esef |
| ifrs:TradeAndOtherCurrentPayables | {"amount": 17736000.0} | 2021-12-31 | esef |
| ifrs:TradeAndOtherCurrentReceivables | {"amount": 0.0} | 2022-12-31 | esef |
| ifrs:TradeAndOtherCurrentReceivables | {"amount": 0.0} | 2021-12-31 | esef |
| income_tax_expense | {"amount": 0.0, "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations"} | 2022-12-31 | esef |
| income_tax_expense | {"amount": 0.0, "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations"} | 2021-12-31 | esef |
| legal_address | {"city": "Göteborg", "region": "SE-O", "street": "C/O Biotech Center, Arvid Wallgrens, Bac | gleif | |
| legal_jurisdiction | {"value": "SE", "scheme": "ISO 3166"} | gleif | |
| legal_name | {"lang": "sv", "value": "Isofol Medical AB (publ)"} | gleif | |
| net_income | {"amount": -159755000.0, "concept": "ifrs-full:ProfitLoss"} | 2022-12-31 | esef |
| net_income | {"amount": -200251000.0, "concept": "ifrs-full:ProfitLoss"} | 2021-12-31 | esef |
| operating_income | {"amount": -167460000.0, "concept": "ifrs-full:ProfitLossFromOperatingActivities"} | 2022-12-31 | esef |
| operating_income | {"amount": -204465000.0, "concept": "ifrs-full:ProfitLossFromOperatingActivities"} | 2021-12-31 | esef |
| ppe_net | {"amount": 4013000.0, "concept": "ifrs-full:PropertyPlantAndEquipment"} | 2022-12-31 | esef |
| ppe_net | {"amount": 1745000.0, "concept": "ifrs-full:PropertyPlantAndEquipment"} | 2021-12-31 | esef |
| pretax_income | {"amount": -159755000.0, "concept": "ifrs-full:ProfitLossBeforeTax"} | 2022-12-31 | esef |
| pretax_income | {"amount": -200251000.0, "concept": "ifrs-full:ProfitLossBeforeTax"} | 2021-12-31 | esef |
| registration_status | {"entity_status": "ACTIVE", "lei_registration_status": "ISSUED"} | gleif | |
| revenue | {"amount": 12797000.0, "concept": "ifrs-full:Revenue"} | 2022-12-31 | esef |
| revenue | {"amount": 22407000.0, "concept": "ifrs-full:Revenue"} | 2021-12-31 | esef |
| stockholders_equity | {"amount": 158479000.0, "concept": "ifrs-full:Equity"} | 2022-12-31 | esef |
| stockholders_equity | {"amount": 318233000.0, "concept": "ifrs-full:Equity"} | 2021-12-31 | esef |
| stockholders_equity | {"amount": 66567000.0, "concept": "ifrs-full:Equity"} | 2020-12-31 | esef |
| total_assets | {"amount": 213464000.0, "concept": "ifrs-full:Assets"} | 2022-12-31 | esef |
| total_assets | {"amount": 401363000.0, "concept": "ifrs-full:Assets"} | 2021-12-31 | esef |
| total_liabilities | {"amount": 54985000.0, "concept": "ifrs-full:Liabilities"} | 2022-12-31 | esef |
| total_liabilities | {"amount": 83130000.0, "concept": "ifrs-full:Liabilities"} | 2021-12-31 | esef |
Cite as: FACTANKER, https://factanker.com/entity/ac4f787e-c234-4b2d-ad89-7fae83b7750b